Pancreatitis during therapy of acute myeloid leukemia: Cytarabine related?

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Clara D. Bloomfield, David Lawrence, John C. Byrd et al. · PubMed · 1998 · 696 citations

Medicine, Oncology, Pharmacology +15

Cerebellar toxicity with high-dose cytosine arabinoside.

R H Herzig, John Hines, Geoffrey P. Herzig et al. · Journal of Clinical Oncology · 1987 · 164 citations

Pharmacy, Oncology, Pharmacology +16

Improved survival for patients with acute myelogenous leukemia.

Anna Mitus, K B Miller, David P. Schenkein et al. · Journal of Clinical Oncology · 1995 · 112 citations

Medicine, Oncology, Cell Therapy +13

Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukemia

Börje S. Andersson, Brad M. Cogan, Michael J. Keating et al. · Cancer · 1985 · 95 citations · Full text

Medicine, Hematology, Oncology +15

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Eric H. Rubin, J. W. Andersen, Deborah Berg et al. · Journal of Clinical Oncology · 1992 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +17